The effect of the aqueous extract of ZLF at a dose of 400 mg/kg on ALT and AST levels tends towards bioequivalence with silymarin treatment, a potent drug commonly administered against liver fibrosis and considered standard of care in that respect. This evidence concerns the gene GPT and Hepatic fibrosis.